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Staphylococcus aureus epidemic strain USA300 is a highly successful pathogen. However, the underlying
basis of this success is not clear. Now, Thurlow and colleagues (2013) provide evidence linking the bacterial
arginine catabolic mobile element (ACME) to the dominance of USA300 as a pathogen of the skin.Human skin provides a physical barrier
and first line of immunological defense
against noxious stimuli and harmful insult.
External layers of the skin are particularly
inhospitable to pathogenic microbes.
The lowmoisture content, marked acidity,
and abundance of resident microbes on
the outer layers of the skin, the epidermis,
provide a physical barrier that can keep
the most successful pathogens at bay
(Miller and Cho, 2011). If an organism
breaches these physical barriers, the
skin has the capacity to recognize
molecular determinants of pathogenic
microbes to facilitate host cell signaling
and immune cell chemotaxis, thereby
bolstering the immune response and
providing an additional level of defense
(Miller and Cho, 2011).
Staphylococcus aureus is a bacterium
that is capable of rapid adaptation to
host insult in order to promote survival in
disparate conditions. The organism is
notorious for its ability to cause skin and
soft tissue infections. Through gene
acquisition and alterations in regulatory
networks, S. aureus is able to counter
the physical and immunological barriers
of the skin. Some of its defense tactics
include the production of specialized
binding proteins, immune evasion mole-cules, and immune cell targeting toxins
(Foster, 2005). As a result, S. aureus
has become one of the leading causa-
tive agents of skin and soft tissue infec-
tions. Its environmental adaptability
coupled with an increase in antibiotic
resistance among infectious isolates
make S. aureus a major public health
concern.
S. aureus strains exhibit periodic shifts
in the clonal lineage responsible for wide-
spread disease (Li et al., 2009). In the
USA, the current epidemic strain of meth-
icillin-resistant S. aureus, MRSA, is the
sequence type 8 strain, USA300. Consid-
erable attention has been given to the
analysis of USA300 virulence and the
factors responsible for its rise to domi-
nance in both community and clinical
settings (Li et al., 2009; Montgomery
et al., 2008). Indeed, well-known virulence
factors such as alpha hemolysin, phenol
soluble modulins (PSMs), and the Pan-
ton-Valentine leukocidin are produced at
higher levels in these strains (Li et al.,
2009). Additionally, USA300 isolates
have higher activities of gene regulatory
systems including the accessory gene
regulatory system Agr (Li et al., 2009).
While increased Agr activity and en-
hanced production of toxins are likely tocontribute to the overall pathogenic
potential of USA300, they do not fully
explain its propensity to cause skin and
soft tissue infection.
An additional genetic locus harbored by
USA300 strains is the arginine catabolic
mobile element (ACME). ACME is a 33-
gene locus that contains genes important
for arginine catabolism (Arc), an oligo-
peptide permease system (opp3), and
a polyamine N-acetyl transferase (speG).
In USA300, ACME is genetically linked
to the staphylococcal chromosomal
cassette mec (SCCmec) type IVa (Diep
et al., 2008). SCCmec confers b-lactam
resistance to S. aureus. The genetic
linkage between SCCmec and ACME
was observed by Diep et al. and is
believed to be present in nearly all
USA300 isolates (Diep et al., 2008). It
was postulated that the presence of
ACME, which confers a modest fitness
advantage to USA300, coupled with the
antibiotic resistance associated with
SCCmec typeIVa could provide a suitable
explanation for the increased dominance
of USA300. However, additional studies
have demonstrated that the increased
fitness of ACME-containing USA300
strains may not necessarily lead to an
increase in virulence (Montgomery et al.,13, January 16, 2013 ª2013 Elsevier Inc. 3
Figure 1. Simplified Schematic of the Contribution of ACME to S. aureus USA300 Survival on and within Human Skin
(A) Skin colonization by S. aureus is facilitated by neutralizing the acidic pH of human sweat via the production of ammonia (NH4
+) from L-arginine catabolism.
(B) Upon breaching the epidermal layer, a rapid inflammatory phase begins. Neutrophils and iNOS-producing macrophages are recruited to the site of infection.
iNOS uses L-arginine to produce NO$ to fight infection. S. aureus counters this innate immune attack via upregulation of the nitric oxide-inducible lactate
dehydrogenase (ldh1). Excess L-arginine is scavenged by S. aureus, depleting arginine pools from the host and increasing L-ornithine as a by-product.
(C) As infection proceeds, a postinflammatory phase begins. Expression of Arg-1 by host macrophages leads to the synthesis of polyamines, which are critical for
wound healing and toxic toward most S. aureus strains. USA300 uses the ACME-encoded speG to counter polyamine toxicity. S. aureus continues to scavenge
L-arginine and produces L-ornithine as a product of its catabolism. The increased L-ornithine feeds into host-derived polyamine synthesis pathways, further
necessitating SpeG for S. aureus survival.
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that there is no pathologic difference
between ACME-containing USA300
strains and those that do not contain the
element in rat pneumonia and murine
skin and soft tissue infection models
(Montgomery et al., 2009). It would
appear from these studies that enhanced
fitness does not necessarily equate to
enhanced virulence.
A manuscript by Joshi et al. recently
provided additional insight into the func-
tional role of genes encoded within
ACME (Joshi et al., 2011). S. aureus is
one of a number of bacterial species that
lack the ability to synthesize polyamines.
Polyamines are aliphatic compounds,
many of which are synthesized from
L-arginine, that facilitate countless
cellular functions including wound healing
and inflammation. Interestingly, the
majority of S. aureus clones are sensitive
to exogenous polyamines in culture,
except for USA300 (Joshi et al., 2011). In
their studies, the authors link polyamine
resistance in USA300 to the polyamine
N-acetyltransferase SpeG, encoded on
ACME. The acquisition of polyamine
resistance through SpeG was intriguing;4 Cell Host & Microbe 13, January 16, 2013 ªhowever, the study did not demonstrate
a role for polyamine resistance inS. aureus
pathogenesis. Thus, while functional
activities are being assigned to gene
products within ACME, we still do not
know what role this element may have in
the pathogenesis of USA300.
In this issue of Cell Host & Microbe,
Thurlow and colleagues (Thurlow et al.,
2013) now provide evidence that links
the functional activities of ACME genes
with the virulence of USA300 during skin
and soft tissue infections. As described,
the skin provides a formidable barrier to
infection, yet recent evidence suggests
an ability of USA300 to colonize this niche
at higher rates than other strains (Miko
et al., 2012). One of the key physical
features preventing bacterial colonization
of the skin is its acidic pH (Figure 1). In this
work, the authors use broth culture
viability studies to demonstrate that the
arginine deiminase system encoded by
ACME (Arc) is responsible for the
enhanced acid tolerance of USA300 in
the presence of exogenous lactic acid,
the major organic acid present on human
skin. Arc increases the production of
ammonia from L-arginine catabolism,2013 Elsevier Inc.thereby countering this acidic stress
(Figure 1). The authors further demon-
strate that the constitutive activity of
ACME-Arc drives ammonia production
regardless of the presence of glucose or
oxygen, a unique feature of ACME that
sets it apart from the arginine deiminase
system encoded in the chromosome of
all S. aureus strains. Thus, through
ACME, USA300 is better able to resist
the acidic environment of skin, implying
a unique colonization advantage for this
strain.
Once the skin is colonized, S. aureus
can breach the epidermis, leading to
skin and soft tissue infections. Hallmarks
of these infections include a rapid pro-
inflammatory phase marked by the infil-
tration of large numbers of phagocytic
leukocytes. This phase is characterized
by abundant production of NO$ (derived
from L-arginine) by host phagocytes to
which S. aureus strains are known to be
resistant (Richardson et al., 2008) (Fig-
ure 1). A postinflammatory phase then
follows, characterized by an increased
production of polyamines from L-arginine
via the upregulation of host-derived
Arginase-1 (Arg-1) (Figure 1). Increased
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restrictive to S. aureus growth, given the
sensitivity of most strains to these mole-
cules (Joshi et al., 2011). However,
USA300 strains contain ACME-encoded
speG, which confers resistance to poly-
amine toxicity in vitro (Joshi et al., 2011).
Here, the authors extend this finding using
in vivo models to demonstrate that speG
mutants in USA300 display increased
sensitivity to polyamines during the
postinflammatory phase of skin and soft
tissue infection. Further, their data indi-
cate that bacterial burden in late-stage
abscesses is largely dependent on
SpeG, a novel finding that links ACME to
persistence during skin and soft tissue
infection.
Thurlow et al. continue their investiga-
tion into the role of ACME in skin infections
by addressing an apparent paradox
between their findings and that of earlier
studies, which were unable to uncover
a role for ACME in skin and soft tissue
infections (Montgomery et al., 2009). The
authors demonstrate that if speG is
deleted, bacterial burden is significantly
reduced and clearance occurs more
quickly in vivo. However, it was previously
observed that an ACME mutant (lacking
speG and arc) is equally as virulent as an
ACME-containing strain (Montgomery
et al., 2009). Thus, it is somewhat perplex-ing that an ACMEmutant is not also atten-
uated in vivo. Through the use of murine
infection models, the authors rationalize
these findings by demonstrating that
S. aureus Arc diverts L-arginine away
from NO$ production by the host, thereby
fostering polyamine synthesis, a result of
the increased production of L-ornithine
by the bacterium (Figure 1). The presence
of Arc appears to enhance host polyamine
production and requires SpeG to detoxify
the system. Indeed, deletion of arc in
a speG mutant increases the virulence of
the strain to WT levels. Thus, the fitness
advantage conferred upon USA300 via
ACME requires both Arc and SpeG.
All together, the work presented in this
new study both describes a novel role
for ACME as an important virulence deter-
minant in USA300 skin and soft tissue
infection and provides a unique rationale
for how this strain may have rapidly out-
competed other S. aureus clones for
dominance over the human skin niche.
Furthermore, it highlights the remarkable
adaptability of S. aureus in the face of
host immunity, one that extends beyond
traditional mechanisms of pathogenesis
(toxins, immune-modulatory molecules,
etc.). It is worth mentioning that these
findings do not discount the role of major
virulence factors in S. aureus skin and soft
tissue infections; rather, they add to theCell Host & Microbeever-evolving armament of S. aureus
survival mechanisms.REFERENCES
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Trypanosoma cruzi has a complex relationship with its mammalian host in which parasite and host metabolic
networks are intertwined. A genome-wide functional screen of T. cruzi infection in HeLa cells (Caradonna
et al., 2013) divulges host metabolic functions and signaling pathways that impact intracellular parasite
replication and reveals potential targets for therapeutic exploitation.Chagas’ disease is a devastating, perni-
cious, and often fatal disease of the
cardiovascular system for which thehemoflagellate protozoan parasite, Try-
panosoma cruzi, is the etiologic agent.
The neurological system and digestivetract can also be impacted by T. cruzi
infection. Chagas’ disease is endemic to
all 22 countries of South and Central13, January 16, 2013 ª2013 Elsevier Inc. 5
